These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 19019967)
1. Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression. Johansson P; Jansson A; Rüetschi U; Rymo L J Virol; 2009 Feb; 83(3):1393-401. PubMed ID: 19019967 [TBL] [Abstract][Full Text] [Related]
2. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes. Thornburg NJ; Raab-Traub N J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446 [TBL] [Abstract][Full Text] [Related]
3. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma. Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3. Kung CP; Raab-Traub N J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway. Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871 [TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit. Ning S; Hahn AM; Huye LE; Pagano JS J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551 [TBL] [Abstract][Full Text] [Related]
7. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB. Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943 [TBL] [Abstract][Full Text] [Related]
8. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter. Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375 [TBL] [Abstract][Full Text] [Related]
9. The LMP1 promoter can be transactivated directly by NF-kappaB. Demetriades C; Mosialos G J Virol; 2009 May; 83(10):5269-77. PubMed ID: 19279104 [TBL] [Abstract][Full Text] [Related]
10. NF-kappaB only partially mediates Epstein-Barr virus latent membrane protein 1 activation of B cells. Liljeholm S; Hughes K; Grundström T; Brodin P J Gen Virol; 1998 Sep; 79 ( Pt 9)():2117-25. PubMed ID: 9747720 [TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of CCAAT enhancer-binding protein (C/EBP) as a transcriptional activator for Epstein-Barr virus oncogene latent membrane protein 1. Noda C; Murata T; Kanda T; Yoshiyama H; Sugimoto A; Kawashima D; Saito S; Isomura H; Tsurumi T J Biol Chem; 2011 Dec; 286(49):42524-42533. PubMed ID: 22013073 [TBL] [Abstract][Full Text] [Related]
12. LMP1-augmented kappa intron enhancer activity contributes to upregulation expression of Ig kappa light chain via NF-kappaB and AP-1 pathways in nasopharyngeal carcinoma cells. Liu H; Zheng H; Duan Z; Hu D; Li M; Liu S; Li Z; Deng X; Wang Z; Tang M; Shi Y; Yi W; Cao Y Mol Cancer; 2009 Oct; 8():92. PubMed ID: 19860880 [TBL] [Abstract][Full Text] [Related]
13. Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site. Jansson A; Johansson P; Li S; Rymo L J Gen Virol; 2007 Jul; 88(Pt 7):1887-1894. PubMed ID: 17554019 [TBL] [Abstract][Full Text] [Related]
15. Regulation of DNA polymerase beta by the LMP1 oncoprotein of EBV through the nuclear factor-kappaB pathway. Faumont N; Le Clorennec C; Teira P; Goormachtigh G; Coll J; Canitrot Y; Cazaux C; Hoffmann JS; Brousset P; Delsol G; Feuillard J; Meggetto F Cancer Res; 2009 Jun; 69(12):5177-85. PubMed ID: 19491276 [TBL] [Abstract][Full Text] [Related]
16. Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor. Murata T; Noda C; Narita Y; Watanabe T; Yoshida M; Ashio K; Sato Y; Goshima F; Kanda T; Yoshiyama H; Tsurumi T; Kimura H J Virol; 2016 Apr; 90(8):3873-3889. PubMed ID: 26819314 [TBL] [Abstract][Full Text] [Related]
17. Autocrine lymphotoxin production in Epstein-Barr virus-immortalized B cells: induction via NF-kappaB activation mediated by EBV-derived latent membrane protein 1. Thompson MP; Aggarwal BB; Shishodia S; Estrov Z; Kurzrock R Leukemia; 2003 Nov; 17(11):2196-201. PubMed ID: 14523478 [TBL] [Abstract][Full Text] [Related]
18. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter. Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037 [TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus-Encoded Latent Membrane Protein 1 Upregulates Glucose Transporter 1 Transcription via the mTORC1/NF-κB Signaling Pathways. Zhang J; Jia L; Lin W; Yip YL; Lo KW; Lau VMY; Zhu D; Tsang CM; Zhou Y; Deng W; Lung HL; Lung ML; Cheung LM; Tsao SW J Virol; 2017 Mar; 91(6):. PubMed ID: 28053105 [TBL] [Abstract][Full Text] [Related]
20. EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Le Clorennec C; Youlyouz-Marfak I; Adriaenssens E; Coll J; Bornkamm GW; Feuillard J Blood; 2006 Mar; 107(5):2070-8. PubMed ID: 16317104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]